VPAC1 biomarkers are expressed on cell surfaces in high densities at the onset of oncogenesis. When VPAC1 receptors are targeted, cancer can be diagnosed early, but specifically, it allows physicians to distinguish […]
Stephen Chang is a scientist and entrepreneur with over 30 years of experience in gene and cell therapy. Brett Johnson: Can you tell us a bit about your background in the field […]
A company is changing the imaging industry with new software that far exceeds all current mammography technology. This breakthrough technology reveals the make up of the entire breast, including what dense tissue usually […]
A new breakthrough energy-based cancer therapy has the ability to kill cancer cells with no side effects in five different cancer cell types: breast, prostate, and the pancreas. This new therapy induces […]
A real-time, in vivo imaging platform guides surgeons during cancer surgery. This breakthrough technology illuminates cancer cells and other diseased tissues at the molecular level, allowing surgeons to take action and better […]
Clifford Reid is the founding CEO of Travera. Previously, Dr. Reid was the founding Chairman, President and Chief Executive Officer of Complete Genomics (NASDAQ:GNOM), a leading developer of whole human genome DNA […]
Travera’s new technology can predict how patients will respond to hundreds of different drugs or drug combinations before the patients even take the drugs. Their new measurement tool, the Suspended Microchannel Resonator […]
Mature pipeline of biopharmaceuticals for rare diseases. Government funding for biodefense business. Overview Soligenix is a two-segment business. They have a biotherapeutics rare disease segment focused on cancer, cancer supportive care and […]
